Search

Search Constraints

You searched for: Author/Creator Beydoun, Said

Search Results

3. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial. Issue 3 (March 2019)

4. Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study. (5th December 2022)

5. Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study. (5th December 2022)

6. Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study. (5th December 2022)

7. Long-term Safety and Efficacy of Efgartigimod in Patients With Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study. (5th December 2022)

10. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. (4th June 2019)